Method operable design region obtained with a partial least squares model inversion in the determination of ten polycyclic aromatic hydrocarbons by liquid chromatography with fluorescence detection-Reference-Cited by-同舟云学术

Method operable design region obtained with a partial least squares model inversion in the determination of ten polycyclic aromatic hydrocarbons by liquid chromatography with fluorescence detection

Published:2021-11 Issue: Volume:1657 Page:462577
ISSN:0021-9673
Container-title:Journal of Chromatography A
language:en
Short-container-title:Journal of Chromatography A

Author:

Arce M.M.,Sanllorente S.,Ruiz S.^ORCID,Sánchez M.S.^ORCID,Sarabia L.A.,Ortiz M.C.^ORCID

Funder

European Regional Development Fund

Ministerio de Economía y Competitividad

Ministerio de Ciencia, Innovación y Universidades

Agencia Estatal de Investigación

Junta de Castilla y León

Consejería de Educación, Junta de Castilla y León

Publisher

Elsevier BV

Subject

Organic Chemistry,General Medicine,Biochemistry,Analytical Chemistry

Reference27 articles.

1. PAT - A Framework for Innovative Pharmaceutical Development, Manufacturing and Quality Assurance, Guidance for Industry,2004

2. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use considerations (ICH) guideline Q8 (R2) on pharmaceutical development - Step 5,2017

3. Design spaces for analytical methods;Rozet;TRAC-Trend. Anal. Chem.,2013

4. Analytical quality by design approach versus conventional approach: Development of HPLC-DAD method for simultaneous determination of etizolam and propranolol hydrochloride;Peraman;J. Liq. Chromatogr. R. T.,2021

5. Risk-based approach for method development in pharmaceutical quality control context: a critical review;Deidda;J. Pharmaceut. Biomed,2018

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic optimization of reverse phase ultra‐high‐performance liquid chromatography method for quantification of nilotinib and its related substances in bulk drug and pharmaceutical formulation using quality by design approach;SEPARATION SCIENCE PLUS;2024-02-07

2. Model inversion and three-way decompositions in the analytical quality by design strategy for the determination of phthalates BY HS-SPME-GC-MS;Talanta;2024-01

3. Quality by Design in Pharmaceuticals: A Review of its Impact on Regulatory Compliance and Product Quality;Drug Research;2023-12-22

4. Development and validation of a stability‐indicating ultra‐high‐performance liquid chromatography method for the estimation of ibrutinib and trace‐level quantification of related substances using quality‐by‐design approach;Biomedical Chromatography;2023-12-11

5. Analytical quality by design using a D-optimal design and parallel factor analysis in an automatic solid phase extraction system coupled to liquid chromatography. Determination of nine PAHs in coffee samples;Chemometrics and Intelligent Laboratory Systems;2023-12